| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |